MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Medline Inc.

Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Aug 5, 2026

$35.19−0.77 (-2.14%)

Close on Oct 19, 2026

Market cap: $30.29B
P/E (TTM): –
Dividend yield: –

Medline Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Cash & Equivalents	1,939	250	1,585	399
Short-Term Investments	0	–	–	–
Cash & Short-Term Investments	1,939	250	1,585	399
Receivables	3,533	3,219	–	–
Inventory	4,769	4,456	–	–
Other Current Assets	438	398	–	–
Total Current Assets	10,679	8,272	–	–
Property, Plant & Equipment	4,778	4,595	–	–
Gross Property, Plant & Equipment	5,939	5,456	–	–
Accumulated Depreciation	-1,161	-861	–	–
Operating Lease Right-of-Use Assets	432	384	–	–
Goodwill	8,079	8,065	7,532	–
Intangible Assets	13,893	14,559	–	–
Deferred Tax Assets	583	0	–	–
Other Long-Term Assets	23,027	23,111	–	–
Total Assets	38,484	35,978	–	–
Accounts Payable	961	869	–	–
Accrued Expenses	1,452	1,493	–	–
Short-Term Debt	1.00	2.00	–	–
Current Portion of Long-Term Debt	76	76	–	–
Current Debt	77	78	–	–
Current Portion of Leases	66	76	–	–
Current Income Taxes Payable	24	4.00	–	–
Total Current Liabilities	2,490	2,440	–	–
Long-Term Debt	12,484	16,416	–	–
Long-Term Leases	386	329	–	–
Operating Lease Liabilities	452	405	–	–
Other Long-Term Liabilities	682	598	–	–
Total Liabilities	19,198	19,454	–	–
Total Debt	12,561	16,494	–	–
Preferred Stock	0	–	–	–
Additional Paid-In Capital	10,717	–	–	–
Retained Earnings	-7.00	–	–	–
Comprehensive Income & Other	27	11	–	–
Shareholders' Equity	10,737	–	–	–
Noncontrolling Interest	8,549	–	–	–
Total Equity	19,286	–	–	–
Total Liabilities & Equity	38,484	35,978	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 27, 2026

Profitability, FY2025

Gross margin: 26.4%
Operating margin: 7.8%
Net margin: 4.1%
Return on equity, FY2025: –

Financial strength

Current ratio: 4.33
Debt to equity: 1.09
Debt to assets: 32.0%
Cash to current liabilities: 85.9%

Valuation

P/E ratio: –
Price to sales: 1.07
Price to book: 2.62
Dividend yield: –